RUNX1 and acute myeloid leukemia: Consistent with our RUNX1-KO HSPC model, RUNX1mut AML cells expressed higher levels of IL3RA transcripts compared with RUNX1-WT (RUNX1wt) AML cells, with no difference in CSF2RA or CSF3R expression (Figure 5, E–G).